For the latest COVID information Click Here.
Updated July 2024
Secukinumab (brand name: Cosentyx®) is a medicine used to treat adults with psoriatic arthritis, a type of joint inflammation that often occurs with the skin condition called psoriasis. Secukinumab is also used to treat adults with moderate to severe plaque psoriasis that is chronic (lasts for a long time).
Secukinumab may also be used to treat adults with axial spondyloarthritis, including ankylosing spondylitis, a condition which causes inflammation in the spinal joints, resulting in pain and stiffness in the spine.
Secukinumab works by recognising and binding to an inflammatory protein called Interleukin 17A (IL-17A). In patients with psoriatic arthritis and axial spondyloarthritis, the body makes too much IL-17A which is a cause of stiff and painful joints. This means secukinumab can reduce the inflammation and symptoms caused by having too much IL-17A.
It may take a number of weeks for you to notice some relief of joint swelling, pain and stiffness.
If you stop or delay your secukinumab treatment, your condition may get worse. Keep on your treatment unless your rheumatologist tells you to stop or unless you get side effects (see Side effects).
If you stop secukinumab for any reason, you must contact your rheumatologist. If you don’t, your treatment may no longer be subsidised by Medicare.
Medicines like secukinumab are very expensive, but Medicare usually helps cover the cost. You can use it if you meet certain conditions.
Secukinumab is injected just under the skin of the thigh or belly. It is best to avoid (if possible) any areas of skin affected by psoriasis. The prefilled autoinjector or syringe should be taken out of fridge 30 minutes before injecting so it can reach room temperature. Do not shake or freeze it. It can be injected by your doctor, nurse, carer, or by you. If injecting yourself, be sure to follow the detailed instructions carefully to ensure the best response. It is important to change the injection site each time.
If you miss an injection: Give the next injection as soon as you remember and continue to use it as you normally would. Do not inject a double dose to make up for a missed dose. If you have missed more than one dose or are not sure what to do, check with your doctor or pharmacist.
Secukinumab comes in a pre-filled syringe or pen which has 150mg of medicine. In psoriatic arthritis and axial spondyloarthritis, the usual dose of secukinumab is 150mg (the contents of one pre-filled pen) or 300mg (two pens at a time) injected each week for the first 5 weeks of treatment, then once every 4 weeks after that.
This medicine may be used alone or with other arthritis medicines including:
You might experience side effects with your treatment. Tell your doctor if you notice side effects that you think are caused by this medicine. Many side effects disappear when secukinumab treatment is stopped.
There are some rare but potentially serious side effects with secukinumab including:
Other side effects not listed in this leaflet may also occur. Tell your doctor if you notice any other side effects that you think might be caused by secukinumab.
Infections
If you have an active infection of any kind, treatment with secukinumab will not be started until the infection is gone. Serious infections such as tuberculosis (TB) are seen rarely, and screening for TB may be needed before treatment begins.
Use with other medicines
Use with phototherapy
Vaccines
Surgery
If you need surgery for any reason, you should discuss this with your rheumatologist as some people need to stop taking secukinumab before surgery.
Alcohol
You may drink alcohol while taking secukinumab. However, if you are also taking methotrexate, you should be cautious about how much alcohol you drink.
Use in pregnancy and when breastfeeding